LIN SUE-JEAN
SEC insider (Form 3/4/5 filer). CIK 0001867788. Director at Stevanato Group S.p.A. (STVN) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in WESTLAKE VILLAGE, CA.
Companies LIN SUE-JEAN has filed insider reports for
- Stevanato Group S.p.A. (STVN): Director
- Arcutis Biotherapeutics, Inc. (ARQT): Director
LIN SUE-JEAN
CIK: 0001867788
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
SaleDirect4.9K shares at avg. $24.38$121K - Jun 12, 2026STVN
Stevanato Group S.p.A.
AwardDirect5K shares- - Jun 5, 2026ARQT
Arcutis Biotherapeutics, Inc.
AwardDirect5.8K shares- - Nov 24, 2025ARQT
Arcutis Biotherapeutics, Inc.
ExerciseDirect18.1K shares at avg. $8.63$156K - Nov 24, 2025ARQT
Arcutis Biotherapeutics, Inc.
ExerciseDirect7.2K shares at avg. $7.51$54K - Nov 24, 2025ARQT
Arcutis Biotherapeutics, Inc.
SaleDirect25.3K shares at avg. $30.78$778K - Jun 12, 2025ARQT
Arcutis Biotherapeutics, Inc.
AwardDirect7.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,946 | $24.38 | $120,587 | Direct |
| Jun 12, 2026 |  STVN Stevanato Group S.p.A. | Award | 4,975 | - | $0 | Direct |
| Jun 5, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Award | 5,778 | - | $0 | Direct |
| Nov 24, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Exercise | 18,052 | $8.63 | $155,789 | Direct |
| Nov 24, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Exercise | 7,220 | $7.51 | $54,222 | Direct |
| Nov 24, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale | 25,272 | $30.78 | $777,956 | Direct |
| Jun 12, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Award | 7,609 | - | - | Direct |
1-7 of 7 transactions